Alfa Digital Co., Ltd.
Update：2025/12/24
Industries
Main Industry
Software
Main Product/Service
Future PharmaTech uses its proprietary “Future‑AI platform,” integrating drug repurposing and mechanism simulation to develop novel compounds capable of penetrating the blood‑brain barrier (BBB), targeting conditions such as vascular dementia (VD) and ere
Founded Year
2023
Unified Business No.
94004036
Status
Active
Number of Employees
0
Total Paid-in
Capital
8,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Future PharmaTech, founded in 2021, focuses on neurological and vascular disorders, leveraging its proprietary AI‑driven drug discovery platform and nanomedicine technologies to rapidly develop effective, safe and precision therapies designed to improve p
